Senate Bill 139

Actions
Last Action to Health & Welfare (S)
Title AN ACT relating to use of experimental treatments for terminal illnesses.
Bill Documents Bill
Bill Request Number 1419
Sponsor C. Embry Jr.
Summary of Original Version Create new sections of KRS Chapter 217 to define terms; permit eligible patients to use investigational drugs, biological products, or devices for a terminal illness; establish the conditions for use of such experimental treatments; prohibit sanctions of health care providers; clarify the duties of health care insurers regarding experimental treatments; prohibit certain actions by state officials; provide immunity for use and recommendation of experimental treatments.
Index Headings of Original Version Diseases - Investigational drugs, biological products, or devices, use by terminal patients
Drugs and Medicines - Investigational drugs, biological products, or devices, use by terminal patients
Health and Medical Services - Terminal patients, investigational drugs, biological products, or devices
Nurses - Investigational drugs, bioloical products, or devices, use by terminal patients
Pharmacists - Investigational drugs, biological products, or devices, use by terminal patients
Physicians and Practitioners - Investigational drugs, biological products, or devices, use by terminal patients
Public Health - Investigational drugs, biological products, or devices, use by terminal patients

Actions

Top
02/10/15
  • introduced in Senate
02/12/15
  • to Health & Welfare (S)


Last updated: 1/16/2019 3:10 PM (EST)